Should we be screening for and treating periodontal disease in individuals who are at risk of rheumatoid arthritis?

Mustufvi, Z., Serban, S. , Chesterman, J. and Mankia, K. (2021) Should we be screening for and treating periodontal disease in individuals who are at risk of rheumatoid arthritis? Healthcare, 9(10), 1326. (doi: 10.3390/healthcare9101326) (PMID:34683006) (PMCID:PMC8544588)

Abstract

There is increasing evidence supporting an association between periodontal disease (PD) and rheumatoid arthritis (RA), both mechanistically and clinically. Trials have shown that treating PD in people with RA may improve RA disease activity. Patients with musculoskeletal symptoms without arthritis, who test positive for cyclic-citrullinated protein antibodies, are at risk of RA (CCP+ at-risk), with seropositivity preceding arthritis onset by months or years. Importantly, there is evidence to suggest that periodontal inflammation may precede joint inflammation in CCP+ at-risk and, therefore, this could be a trigger for RA. There has been increased research interest in RA prevention and the phenotyping of the pre-RA disease phase. This review will examine the merits of identifying individuals who are CCP+ at-risk and performing screening for PD. In addition, we discuss how PD should be treated once identified. Finally, the review will consider future research needed to advance our understanding of this disease association.

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Serban, Dr Stefan
• Authors: Mustufvi, Z., Serban, S., Chesterman, J., and Mankia, K.
• College/School: College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Dental School
• Journal Name: Healthcare
• Publisher: MDPI
• ISSN: 2227-9032
• ISSN (Online): 2227-9032
• Copyright Holders: Copyright © 2021 The Authors
• First Published: First published in Healthcare 9(10):1326
• Publisher Policy: Reproduced under a Creative Commons License